Cerys Pharmaceuticals

Mumbai, India
Pharmaceutical products and services across therapy areas such as pediatric and nutrition.
Annual revenue $117,227 Latest available
Total funding - Funding intelligence
Employees 24 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Cerys Pharmaceuticals

Cerys Pharmaceuticals is a company based in Mumbai (India). The company has 24 employees as of April 04, 2024. Cerys Pharmaceuticals offers products and services including Pediatric Medicines and Nutritional Supplements.

  • Headquarter Mumbai, India
  • Employees 24 as on 04 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Cerys Pharmaceuticals Pvt. Ltd
  • Jurisdiction Sion, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $117.23 K (USD)
    50.17
    as on Mar 31, 2023
  • Net Profit
    -$90.68 K (USD)
    -76.85
    as on Mar 31, 2023
  • EBITDA
    -$93.9 K (USD)
    -93.6
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    24

    as on Apr 04, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cerys Pharmaceuticals

Cerys Pharmaceuticals offers a comprehensive portfolio of products and services, including Pediatric Medicines and Nutritional Supplements.

Product name locked
Category locked
Primary

Medicines for pediatric care are offered across various formulations to address health needs in children.

Product name locked
Category locked
Locked

Supplements for nutrition are provided to support overall health and wellness in different therapy areas.

Funding Insights of Cerys Pharmaceuticals

Premium access

Detailed funding history for Cerys Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cerys Pharmaceuticals

Investments
Premium access

Investment portfolio details for Cerys Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Cerys Pharmaceuticals

Premium access

Detailed financials for Cerys Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cerys Pharmaceuticals Comparisons

Cerys Pharmaceuticals Primary company
Description
Pharmaceutical products and services across therapy areas su...
Location
Mumbai, India
Founded Year
-
Annual Revenue
$117.23 K (USD)
Net Profit
-$90.68 K (USD)
EBITDA
-$93.9 K (USD)
Employees
24
As of 2024
Premium access

Peer comparison for Cerys Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cerys Pharmaceuticals

Premium access

Detailed competitors of Cerys Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cerys Pharmaceuticals

Premium access

Complete news archive for Cerys Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cerys Pharmaceuticals

Cerys Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

As of Apr 04, 2024, the latest employee count at Cerys Pharmaceuticals is 24.

Annual revenue of Cerys Pharmaceuticals is $117.23K as on Mar 31, 2023.

Cerys Pharmaceuticals is recognized as an emerging company that is committed to addressing unmet medical and societal needs through a comprehensive pharmaceutical value chain extending across the nation. It was established in 2020 with a strong emphasis on patient centricity and a dedicated core team. A mission of pursuing excellence in healthcare is adopted to deliver essential values that fulfill unmet medical requirements, while a vision focuses on elevating healthcare standards through human expertise to become a respected entity in the field.

Cerys Pharmaceuticals offers Pediatric Medicines and Nutritional Supplements.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available